Non-adherence and non-response in the treatment of anxiety disorders

Journal of Anxiety Disorders

Volumn 26, Issue 5, 2012, Pages 583-589

  Taylor, Steven ^a   Abramowitz, Jonathan S ^b   McKay, Dean ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c FORDHAM UNIVERSITY   (United States)

Author keywords

Anxiety disorders; Non adherence; Non response; Treatment dropout; Treatment failure

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; COGNITIVE THERAPY; COMORBIDITY; DISEASE SEVERITY; EMOTIONALITY; ENVIRONMENTAL FACTOR; FAMILY; HUMAN; MENTAL DISEASE; MOTIVATION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREDICTION; PROGNOSIS; REVIEW; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

ANXIETY DISORDERS; COGNITIVE THERAPY; HEALTH BEHAVIOR; HUMANS; PATIENT COMPLIANCE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84860642857     PISSN: 08876185     EISSN: 18737897     Source Type: Journal    
DOI: 10.1016/j.janxdis.2012.02.010     Document Type: Review

References (60)

1. Abramowitz J.S., Deacon B.J., Whiteside S.P. Exposure therapy for anxiety: principles and practice 2011, Guilford Press, New York.
2. Abramowitz J.S., Franklin M.E., Street G.P., Kozak M.J., Foa E.B. Effects of comorbid depression on response to treatment for obsessive-compulsive disorder. Behavior Therapy 2000, 31:517-528.
3. Abramowitz J.S., Franklin M., Zoellner L., DiBernardo C. Treatment compliance and outcome in obsessive-compulsive disorder. Behavior Modification 2002, 26:447-463.
4. Abramowitz J.S., Taylor S., McKay D. Obsessive-compulsive disorder. The Lancet 2009, 374:491-499.
5. Anderson I. The new guidelines from the British Association for Psychopharmacology for anxiety disorders. International Journal of Psychiatry in Clinical Practice 2006, 10(Suppl. 3):10-17.
6. Bloch M.M., McGuire J., Landeros-Weisenberger A., Leckman J.F., Pittenger C. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Molecular Psychiatry 2010, 15:850-855.
7. Bordin E.S. The generalizability of the psychoanalytic concept of the working alliance. Psychotherapy: Theory, Research, and Practice 1979, 16:252-260.
8. Borenstein M., Hedges L.V., Higgins J., Rothstein H. Introduction to meta-analysis 2009, Wiley, Chichester.
9. Bradley R., Greene J., Russ E., Dutra L., Westen D. A multidimensional meta-analysis of psychotherapy for PTSD. American Journal of Psychiatry 2005, 162:214-227.
10. Bryant R.A., Felmingham K., Kemp A., Das P., Hughes G., Peduto A., Williams L. Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychological Medicine 2008, 38:555-561.
11. Butzlaff R.L., Hooley J.M. Expressed emotion and psychiatric relapse: a meta-analysis. Archives of General Psychiatry 1998, 55:547-552.
12. Chambless D.L., Steketee G. Expressed emotion and behavior therapy outcome: a prospective study with obsessive-compulsive and agoraphobic outpatients. Journal of Consulting and Clinical Psychology 1999, 67:658-665.
13. Davidson J.R.T., Rothbaum B.O., van der Kolk B.A., Sikes Farfel G.M. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Archives of General Psychiatry 2001, 58:485-492.
14. Eddy K.T., Dutra L., Bradley R., Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clinical Psychology Review 2004, 24:1011-1030.
15. Erwin B.A., Heimberg R.G., Juster H., Mindlin M. Comorbid anxiety and mood disorders among persons with social anxiety disorder. Behaviour Research and Therapy 2002, 40:19-35.
16. Erzegovesi S., Cavallini M.C., Cavedini P., Diaferia G., Locatelli M., Bellodi L. Clinical predictors of drug response in obsessive-compulsive disorder. Journal of Clinical Psychopharmacology 2001, 21:488-492.
17. Fedoroff I.C., Taylor S. Psychological and pharmacological treatments of social phobia: a meta-analysis. Journal of Clinical Psychopharmacology 2001, 21:311-324.
18. Foa E.B., Abramowitz J.S., Franklin M.E., Kozak M.J. Feared consequences, fixity of belief, and treatment outcome in patients with obsessive-compulsive disorder. Behavior Therapy 1999, 30:717-724.
19. Fogler J., Thomson M.C., Steketee G., Hofmann S.G. Influence of expressed emotion and perceived criticism on cognitive-behavioral therapy for social phobia. Behaviour Research and Therapy 2007, 45:235-249.
20. Hofmann S.G., Richey J.A., Asnaani A., Sawyer A.T. Avoiding treatment failure in social anxiety disorder. Avoiding treatment failures in the anxiety disorders 2010, 169-184. Springer, New York. M.W. Otto, S.G. Hofmann (Eds.).
21. Hofmann S.G., Smits J.A.J. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. Journal of Clinical Psychiatry 2008, 69:621-632.
22. Hofmann S.G., Smits J.A.J., Asnaani A., Gutner C.A., Otto M.W. Cognitive enhancers for anxiety disorders. Pharmacology, Biochemistry, and Behavior 2010, 99:275-284.
23. Insel T.R., Scolnick E.M. Cure therapeutics and strategic prevention: raising the bar for mental health research. Molecular Psychiatry 2006, 11:11-17.
24. Jacobson N.S., Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 1991, 59:12-19.
25. Kazantzis N., Whittington C., Datillio F. Meta-analysis of homework effects in cognitive and behavioral therapy: a replication and extension. Clinical Psychology: Science & Practice 2010, 17:144-156.
26. Keeley M.L., Storch E.A., Merlo L.J., Geffken G.R. Clinical predictors of response to cognitive-behavioral therapy for obsessive-compulsive disorder. Clinical Psychology Review 2008, 28:118-130.
27. Keller S.M., Zoellner L.A., Feeny N.C. Understanding factors associated with early therapeutic alliance in PTSD treatment: adherence, childhood sexual abuse history, and social support. Journal of Consulting and Clinical Psychology 2010, 78:974-979.
28. Kessler R., Glasgow R.E. A proposal to speed translation of healthcare research into practice: dramatic change is needed. American Journal of Preventive Medicine 2011, 40:637-644.
29. Kobak K.A., Griest J.H., Jefferson J.W., Katzelnick D.J., Henk H.J. Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis. Psychopharmacology 1998, 136:205-216.
30. Kozak M.J., Foa E.B. Obsessions, overvalued ideation, and delusions in obsessive-compulsive disorder. Behaviour Research and Therapy 1994, 34:343-353.
31. Kuyken W., Fothergill C.D., Musa M., Chadwick P. The reliability and quality of cognitive case formulation. Behaviour Research and Therapy 2005, 43:1187-1201.
32. Laffaye C., Rosen C.S., Schnurr P.P., Friedman M.J. Does compensation status influence treatment participation and course of recovery from post-traumatic stress disorder?. Military Medicine 2007, 172:1039-1045.
33. Lurie I., Levine S.Z. Meta-analysis of dropout rates in SSRIs versus placebo in randomized clinical trials of PTSD. Journal of Nervous and Mental Disease 2010, 198:116-124.
34. McCabe R.E., Antony M.M. Panic disorder and agoraphobia. Improving outcomes and preventing relapse in cognitive-behavioral therapy 2005, 1-37. Guilford, New York. M.M. Antony, D.R. Ledley, R.G. Heimberg (Eds.).
35. Miller W.R., Rollnick S. Motivational interviewing: preparing people for change 2002, Guilford, New York. 2nd ed.
36. Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. Journal of Affective Disorders 2005, 88:27-45.
37. Mitte K., Noack P., Steil R., Hautzinger M. A meta-analytic review of the efficacy of drug treatment for generalized anxiety disorder. Journal of Clinical Psychopharmacology 2005, 25:141-150.
38. Nathan P.E., Gorman J.M. A guide to treatments that work 2007, Oxford University Press, New York. 3rd ed.
39. Newman M.G., Przeworski A., Fisher A.J., Borkovec T.D. Diagnostic comorbidity in adult with generalized anxiety disorder: impact of comorbidity on psychotherapy outcome and impact of psychotherapy on comorbid diagnoses. Behavior Therapy 2010, 41:59-72.
40. Persons J.B., Bertagnoli A. Inter-rater reliability of cognitive-behavioral case formulations of depression: a replication. Cognitive Therapy and Research 1999, 23:271-283.
41. Prochaska J.O., DiClemente C.C. The transtheoretical model of change. Handbook of psychotherapy integration 1992, 300-334. Basic Books, New York. J.C. Norcross, M.R. Goldfried (Eds.).
42. Ramnerö J., öst L.-G. Prediction of outcome in the behavioural treatment of panic disorder with agoraphobia. Behaviour Research and Therapy 2004, 33:176-180.
43. Renshaw K.D., Chambless D.L., Steketee G. The relationship of relatives' attributions to their expressed emotion and to patients' improvement in treatment for anxiety disorders. Behavior Therapy 2006, 37:159-169.
44. Sanderson W.C., Bruce T.J. Causes and management of treatment-resistant panic disorder and agoraphobia: a survey of expert therapists. Cognitive and Behavioral Practice 2007, 14:26-35.
45. Schmidt N.B., Woolaway-Bickel K. The effects of treatment compliance on outcome in cognitive-behavioral therapy for panic disorder: quality versus quantity. Journal of Consulting and Clinical Psychology 2000, 68:13-18.
46. Simpson H.B., Maher M.J., Wang Y., Bao Y., Foa E.B., Franklin M.E. Patient adherence predicts outcome from cognitive-behavioral therapy in obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology 2011, 79:247-252.
47. Stein D.J., Bandelow B., Dolberg O.T., Andersen H.F., Baldwin D.S. Anxiety symptom severity and functional recovery or relapse. Psychiatric Annals 2009, 21:81-88.
48. Steketee G.S., Chambless D.L., Tran G.Q. Effects of axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. Comprehensive Psychiatry 2001, 42:76-86.
49. Taft C.T., Murphy C.M. The working alliance in intervention for partner violence perpetrators: recent research and theory. Journal of Family Violence 2007, 22:11-18.
50. Tarrier N., Sommerfield C., Pilgrim H. Relatives' expressed emotion (EE) and PTSD treatment outcome. Psychological Medicine 1999, 29:801-811.
51. Taylor S. Understanding and treating panic disorder: cognitive-behavioural approaches 2000, Wiley, New York.
52. Taylor S. Clinician's guide to PTSD: a cognitive-behavioral approach 2006, Guilford, New York.
53. Taylor S. Posttraumatic stress disorder. Cognitive-behavioral therapy for refractory cases: turning failure into success 2009, 139-153. American Psychological Association Press, Washington, DC. D. McKay, J.S. Abramowitz, S. Taylor (Eds.).
54. Taylor S., Jang K.L. Biopsychosocial etiology of obsessions and compulsions: an integrated behavioral-genetic and cognitive-behavioral analysis. Journal of Abnormal Psychology 2011, 120:174-186.
55. Tolin D.F., Gilliam C.M., Dufresne D. The economic and social burden of anxiety disorders. Textbook of anxiety disorders 2010, 731-746. American Psychiatric Publishing, Arlington, VA. 2nd ed. D.J. Stein, E. Hollander, B.O. Rothbaum (Eds.).
56. Westen D., Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. Journal of Consulting and Clinical Psychology 2001, 69:875-899.
57. World Health Organization Adherence to long-term therapies: evidence for action 2003, Author, Geneva, Switzerland, Retrieved March 31.03.10 from http://www.who.int/topics/patient_adherence/en/.
58. Yamanishi T., Nakaaki S., Omori I.M., Hashimoto N., Shinagawa Y., Hongo J., Furukawa T.A. Changes after behavior therapy among responsive and nonresponsive patients with obsessive-compulsive disorder. Psychiatry Research: Neuroimaging 2009, 172:242-250.
59. Yedhuda R., Bierer L.M., Sarapas C., Makotkine I., Andrew R., Seckl J.R. Cortisol metabolic predictors of response to psychotherapy for symptoms of PTSD in survivors of the World Trade Center attacks on September 11, 2001. Psychoneuroimmunology 2009, 34:1304-1313.
60. Zayfert C., Black C.B. Implementation of empirically supported treatment for PTSD: obstacles and innovation. The Behavior Therapist 2000, 23. 161-162, 164-168.